These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


964 related items for PubMed ID: 17020994

  • 1. Enhanced antitumor effect of oncolytic adenovirus expressing interleukin-12 and B7-1 in an immunocompetent murine model.
    Lee YS, Kim JH, Choi KJ, Choi IK, Kim H, Cho S, Cho BC, Yun CO.
    Clin Cancer Res; 2006 Oct 01; 12(19):5859-68. PubMed ID: 17020994
    [Abstract] [Full Text] [Related]

  • 2. Concurrent delivery of GM-CSF and B7-1 using an oncolytic adenovirus elicits potent antitumor effect.
    Choi KJ, Kim JH, Lee YS, Kim J, Suh BS, Kim H, Cho S, Sohn JH, Kim GE, Yun CO.
    Gene Ther; 2006 Jul 01; 13(13):1010-20. PubMed ID: 16525479
    [Abstract] [Full Text] [Related]

  • 3. Triple combination of oncolytic herpes simplex virus-1 vectors armed with interleukin-12, interleukin-18, or soluble B7-1 results in enhanced antitumor efficacy.
    Ino Y, Saeki Y, Fukuhara H, Todo T.
    Clin Cancer Res; 2006 Jan 15; 12(2):643-52. PubMed ID: 16428511
    [Abstract] [Full Text] [Related]

  • 4. Strengthening of antitumor immune memory and prevention of thymic atrophy mediated by adenovirus expressing IL-12 and GM-CSF.
    Choi KJ, Zhang SN, Choi IK, Kim JS, Yun CO.
    Gene Ther; 2012 Jul 15; 19(7):711-23. PubMed ID: 21993173
    [Abstract] [Full Text] [Related]

  • 5. Tricistronic viral vectors co-expressing interleukin-12 (1L-12) and CD80 (B7-1) for the immunotherapy of cancer: preclinical studies in myeloma.
    Wen XY, Mandelbaum S, Li ZH, Hitt M, Graham FL, Hawley TS, Hawley RG, Stewart AK.
    Cancer Gene Ther; 2001 May 15; 8(5):361-70. PubMed ID: 11477456
    [Abstract] [Full Text] [Related]

  • 6. In situ expression of soluble B7-1 in the context of oncolytic herpes simplex virus induces potent antitumor immunity.
    Todo T, Martuza RL, Dallman MJ, Rabkin SD.
    Cancer Res; 2001 Jan 01; 61(1):153-61. PubMed ID: 11196154
    [Abstract] [Full Text] [Related]

  • 7. The expression of CD70 and CD80 by gene-modified tumor cells induces an antitumor response depending on the MHC status.
    Douin-Echinard V, Bornes S, Rochaix P, Tilkin AF, Peron JM, Bonnet J, Favre G, Couderc B.
    Cancer Gene Ther; 2000 Dec 01; 7(12):1543-56. PubMed ID: 11228533
    [Abstract] [Full Text] [Related]

  • 8. Combination treatment of murine tumors by adenovirus-mediated local B7/IL12 immunotherapy and radiotherapy.
    Lohr F, Hu K, Haroon Z, Samulski TV, Huang Q, Beaty J, Dewhirst MW, Li CY.
    Mol Ther; 2000 Sep 01; 2(3):195-203. PubMed ID: 10985949
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Combined CXC chemokine and interleukin-12 gene transfer enhances antitumor immunity.
    Palmer K, Hitt M, Emtage PC, Gyorffy S, Gauldie J.
    Gene Ther; 2001 Feb 01; 8(4):282-90. PubMed ID: 11313802
    [Abstract] [Full Text] [Related]

  • 12. A simplified system for generating oncolytic adenovirus vector carrying one or two transgenes.
    Hu ZB, Wu CT, Wang H, Zhang QW, Wang L, Wang RL, Lu ZZ, Wang LS.
    Cancer Gene Ther; 2008 Mar 01; 15(3):173-82. PubMed ID: 18157145
    [Abstract] [Full Text] [Related]

  • 13. Prostate cancer gene therapy: comparison of adenovirus-mediated expression of interleukin 12 with interleukin 12 plus B7-1 for in situ gene therapy and gene-modified, cell-based vaccines.
    Hull GW, Mccurdy MA, Nasu Y, Bangma CH, Yang G, Shimura S, Lee HM, Wang J, Albani J, Ebara S, Sato T, Timme TL, Thompson TC.
    Clin Cancer Res; 2000 Oct 01; 6(10):4101-9. PubMed ID: 11051263
    [Abstract] [Full Text] [Related]

  • 14. Triple gene-deleted oncolytic herpes simplex virus vector double-armed with interleukin 18 and soluble B7-1 constructed by bacterial artificial chromosome-mediated system.
    Fukuhara H, Ino Y, Kuroda T, Martuza RL, Todo T.
    Cancer Res; 2005 Dec 01; 65(23):10663-8. PubMed ID: 16322208
    [Abstract] [Full Text] [Related]

  • 15. Immune gene-viral therapy with triplex efficacy mediated by oncolytic adenovirus carrying an interferon-gamma gene yields efficient antitumor activity in immunodeficient and immunocompetent mice.
    Su C, Peng L, Sham J, Wang X, Zhang Q, Chua D, Liu C, Cui Z, Xue H, Wu H, Yang Q, Zhang B, Liu X, Wu M, Qian Q.
    Mol Ther; 2006 May 01; 13(5):918-27. PubMed ID: 16497559
    [Abstract] [Full Text] [Related]

  • 16. Enhanced antitumor effect of combined replicative adenovirus and nonreplicative adenovirus expressing interleukin-12 in an immunocompetent mouse model.
    Nagayama Y, Nakao K, Mizuguchi H, Hayakawa T, Niwa M.
    Gene Ther; 2003 Aug 01; 10(16):1400-3. PubMed ID: 12883537
    [Abstract] [Full Text] [Related]

  • 17. Interleukin-18 gene transfer increases antitumor effects of suicide gene therapy through efficient induction of antitumor immunity.
    Ju DW, Yang Y, Tao Q, Song WG, He L, Chen G, Gu S, Ting CC, Cao X.
    Gene Ther; 2000 Oct 01; 7(19):1672-9. PubMed ID: 11083476
    [Abstract] [Full Text] [Related]

  • 18. Characterization of the antitumor immune response generated by treatment of murine tumors with recombinant adenoviruses expressing HSVtk, IL-2, IL-6 or B7-1.
    Felzmann T, Ramsey WJ, Blaese RM.
    Gene Ther; 1997 Dec 01; 4(12):1322-9. PubMed ID: 9472556
    [Abstract] [Full Text] [Related]

  • 19. Oncolytic adenovirus coexpressing interleukin-12 and shVEGF restores antitumor immune function and enhances antitumor efficacy.
    Ahn HM, Hong J, Yun CO.
    Oncotarget; 2016 Dec 20; 7(51):84965-84980. PubMed ID: 27821803
    [Abstract] [Full Text] [Related]

  • 20. Successful adoptive immunotherapy of murine poorly immunogenic tumor with specific effector cells generated from gene-modified tumor-primed lymph node cells.
    Tanaka H, Yoshizawa H, Yamaguchi Y, Ito K, Kagamu H, Suzuki E, Gejyo F, Hamada H, Arakawa M.
    J Immunol; 1999 Mar 15; 162(6):3574-82. PubMed ID: 10092816
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 49.